No profile data available.
Exagen Inc. (XGN) is a healthcare company in the additional medical testing equipment industry, based in Vista, United States, with about 216 full-time employees.
It reported revenue of $55.64 million for fiscal year 2024, up 5.9% from fiscal year 2023, and net income of -$15.12 million. In Q3 2025 (the quarter ended September 30, 2025) revenue was $17.24 million, up 37.9% from a year before. Its market capitalization was $203.98 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 9, 2026.
Exagen Inc. designs, develops, and commercializes various testing products under the AVISE brand in the United States.
Exagen reported $55.64 million in revenue for fiscal year 2024, up 5.9% from $52.55 million in fiscal year 2023. In Q3 2025 revenue was $17.24 million.
$203.98 million as of October 9, 2026.
Listed companies of a similar size in the same industry (additional medical testing equipment) include Bio-Rad Laboratories, Inc. (BIO), QuidelOrtho Corporation (QDEL), Global Cord Blood Corporation (CORBF), Biomerica, Inc. (BMRA).